Optimal Use of Anabolic and Antiresorptive Therapies in the Treatment of Postmenopausal Osteoporosis

Dr. Benjamin Leder is an Professor of Medicine at Harvard Medical School and Medical Director of the Massachusetts General Hospital Endocrine Associates. He is an internationally recognized expert in the field of osteoporosis, a clinical investigator, and a practicing physician specializing in the treatment of metabolic bone disease. He is a graduate of Yale University and Harvard Medical School and completed his internal medicine residency and endocrine fellowship at Massachusetts General Hospital in Boston. His initial clinical research focused on using small-scale human physiologic investigation to better defining the role that gonadal steroids play in regulating male bone metabolism as well as other organ systems. More recently, his NIH-funded research group has completed a series of clinical studies aimed at developing novel approaches to combination anabolic/antiresorptive therapy in postmenopausal osteoporosis. Dr. Leder has been on the faculty of the Endocrine Unit at Massachusetts General Hospital since 2000 and is a 2011 inductee in the American Society of Clinical Investigation. He has been active in the Endocrine Society and the American Society of Bone and Mineral Research, where he chaired Profession Practice Committee.